Clinical Trials · NCT07834398

Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes

Phase
Phase 3
Recruitment status
Completed
Sponsor
Zagazig University
Enrollment
150
Start date
Nov 2025
Locations
1 site, Saudi Arabia
Primary endpoint
change in body weight at 3 and 6 months
View Tirzepatide compound reference